Lookup NU author(s): Dr Andrei Soliakov,
Professor Jeremy Lakey
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
An anthrax sub-unit vaccine, comprising recombinant Protective Antigen (rPA83) and aluminium hydroxide adjuvant (Alhydrogel (R)) is currently being developed. Here, a series of biophysical techniques have been applied to free and adjuvant bound antigen. Limited proteolysis and fluorescence identified no changes in rPA83 tertiary structure following binding to Alhydrogel and the bound rPA83 retained two structurally important calcium ions. For adsorbed rPA83, differential scanning calorimetry revealed a small reduction in unfolding temperature but a large decrease in unfolding enthalpy whilst urea unfolding demonstrated unchanged stability but a loss of co-operativity. Overall, these results demonstrate that interactions between rPA83 and Alhydrogel have a minimal effect on the folded protein structure and suggest that antigen destabilisation is not a primary mechanism of Alhydrogel adjuvancy. This study also shows that informative structural characterisation is possible for adjuvant bound sub-unit vaccines. (C) 2011 Elsevier B.V. All rights reserved.
Author(s): Soliakov A, Kelly IF, Lakey JH, Watkinson A
Publication type: Article
Publication status: Published
Journal: European Journal of Pharmaceutics and Biopharmaceutics
Print publication date: 21/09/2011
ISSN (print): 0939-6411
ISSN (electronic): 1873-3441
Publisher: Elsevier BV
Altmetrics provided by Altmetric